N/A
Completed N=60
Development and Pilot Testing of the Sense2Quit App
Source: ClinicalTrials.gov NCT05609032 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: Percentage of Participants With Biochemically Verified 7-day Point Prevalence Smoking/Tobacco Abstinence at 12 Weeks — 2; 4 Participants
Summary
This is a pilot randomized controlled trial to examine the feasibility, acceptability and preliminary efficacy of the Sense2Quit App in a sample of 60 PLWH who smoke.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With Biochemically Verified 7-day Point Prevalence Smoking/Tobacco Abstinence at 12 Weeks |
2; 4 | — |
Eligibility Criteria
Inclusion Criteria
- PLWH confirmed through medical records or pill bottles for antiretroviral therapy (ART)medications.
- ≥ 18 years of age;
- Own an Android smartphone;
- Understand and read English;
- Not pregnant or breastfeeding (due to contraindications for Nicotine Replacement Therapy [NRT]);
- Permanent contact information;
- Smokes ≥5 cigarettes per day for the past 30 days;
- Interested in quitting smoking within 30 days;
- Blows ≥5 ppm eCO into a breath analyzer at baseline.
Exclusion Criteria
- Use of tobacco products other than cigarettes (i.e. cigars, piped tobacco, chew, snuff)
- Planning to move within 3 months of enrollment;
- Positive history of a medical condition that precludes nicotine patch use;
- Current use of NRT or other smoking cessation medications (e.g., Chantix or Zyban);
- Current enrollment in another smoking cessation program.
- Alcohol dependence measured through the AUDIT-C
- A household member is also participating in the Sense2Quit study (due to study contamination).
Data sourced from ClinicalTrials.gov (NCT05609032). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.